Cutler Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$8K	–	7120
2021 Q1	$8K	Buy	+1,000	New	+$155K	﹤0.01%	4057
2020 Q4	–	Sell	-1,900	Closed	-$5K	–	6204
2020 Q3	$5K	Sell	1,900 -7,800	-80%	-$841K	﹤0.01%	3581
2020 Q2	$65K	Buy	9,700 +6,200	+177%	+$658K	0.01%	1589
2020 Q1	$2K	Sell	3,500 -500	-13%	-$49.1K	﹤0.01%	3611
2019 Q4	$12K	Buy	4,000 +3,000	+300%	+$321K	﹤0.01%	2564
2019 Q3	$7K	Hold	1,000	–	–	﹤0.01%	2877
2019 Q2	$25K	Hold	1,000	–	–	﹤0.01%	2046
2019 Q1	$31K	Sell	1,000 -12,000	-92%	-$1.49M	﹤0.01%	1763
2018 Q4	$35K	Sell	13,000 -4,300	-25%	-$508K	﹤0.01%	1713
2018 Q3	$249K	Sell	17,300 -5,200	-23%	-$652K	0.02%	739
2018 Q2	$76K	Sell	22,500 -24,500	-52%	-$2.86M	0.01%	1336
2018 Q1	$139K	Buy	47,000 +12,800	+37%	+$1.53M	0.02%	1005
2017 Q4	$243K	Sell	34,200 -36,700	-52%	-$4.47M	0.01%	858
2017 Q3	$1.39M	Sell	70,900 -157,300	-69%	-$21.4M	0.07%	268
2017 Q2	$1.53M	Buy	228,200 +81,100	+55%	+$9.44M	0.07%	280
2017 Q1	$214K	Sell	147,100 -77,900	-35%	-$10M	0.01%	1135
2016 Q4	$557K	Buy	225,000 +188,900	+523%	+$23.1M	0.03%	642
2016 Q3	$99K	Sell	36,100 -122,500	-77%	-$15.8M	0.01%	1814
2016 Q2	$166K	Buy	158,600 +45,200	+40%	+$6.41M	0.01%	1266
2016 Q1	$443K	Buy	113,400 +85,900	+312%	+$12.6M	0.04%	578
2015 Q4	$406K	Buy	+27,500	New	+$4.8M	0.03%	732

Other funds holding ALXN